- Scanners
- Software solution/application
- Communication Systems
- Storage Systems
The digital pathology market size is valued at USD 612.3 million in 2021, and it is predicted to increase at a CAGR of 12.7 percent from 2022 to 2028, reaching USD 1,03.5 million by 2028. Digital pathology is the practice of examining high-resolution digitally scanned histology images, which may subsequently be used with computer tools and algorithms. It is an image-based platform that allows pathology information to be acquired, managed, and interpreted from a digitized glass slide. Primary diagnosis, diagnostic consultation, intraoperative diagnosis, medical student and resident teaching, manual and semi-quantitative immunohistochemistry (IHC) evaluation, clinical research, diagnostic decision assistance, peer review, and tumor boards are all examples of healthcare uses. After the FDA authorized the first entire slide scanner for use in primary diagnosis in April 2017, the digital pathology market began to gather traction. Many pathology labs in the U.S. and Europe are switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. Scanners had a market worth of USD 387.5 million in 2021, and it is expected to expand at a substantial CAGR between 2022 and 2028. The large share of the scanners segment can be attributed to the high price of scanners, the increasing adoption of digital pathology solutions, increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. By Type segment, human pathology holds the market revenue share of 37.8% and it is estimated to grow with a significant CAGR from 2022 to 2028.
Digital Pathology Market Key Developments:
- In May 2022, Digital pathology firm Indica Labs Nabs CE Mark for AI-Based Prostate Cancer Detection, Gleason Grading Tool.
- In May 2022, Crosscope and Farcast Biosciences joined efforts to reshape the precision oncology landscape via AI-powered pathology.
Global Digital Pathology Market Summary
Study Period
2023-29
Base Year
2022
CAGR
12.7%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Digital Pathology Market Dynamics
The rise in cancer prevalence, as well as the demand for accurate diagnostics, the rise in the geriatric population, and rapid technological advancements, are driving growth in the global digital pathology market. Moreover, the entry of established MedTech players into the digital pathology market is seen as a validation of the concept that the technology can transform the fact of pathology. However, the high cost of digital pathology systems is hampering the market growth. The cost of digital pathology hardware, such as scanners, is a significant obstacle to market growth. The introduction of low-cost scanners will encourage their adoption among pathologists with low or limited budgets.
Digital Pathology Market Regional Analysis
North-America Got Significant Share
The digital pathology market in North America is expected to hold the highest share of 42.8% in 2021 and it is expected to grow at a significant rate in the coming years. The rising prevalence of cancer, rising demand for quality diagnostics, the implementation of favourable reimbursement policies, and the implementation of favourable initiatives by governments in the United States and Canada are major factors driving the growth of the digital pathology market in North America.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Digital Pathology Market Segmentation
By Product Type
By Application
- Research & Academic
- Clinical Research & Toxicology
- Clinical Diagnostics
By Usage
- Human Pathology
- Animal Pathology
By End User
- Hospitals
- Reference Labs & Pathologists
- Pharmaceutical Companies
- Teaching & Research Institutes
- Others (vet, clinics etc.)
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
- Perkin Elmer Inc. (U.S.)
- Olympus Corporation (Japan)
- Spectra AB (Sweden)
- Philips Healthcare (U.S.)
- Danaher Corporation (Leica Microsystems) (U.S.)
- ZEISS Group (Germany)
- Roche Diagnostics (Germany)
- DigiPath Corp (U.S.)
- 3D-Histech Ltd (Hungary)
- GE Healthcare (U.S.)